About Novo Genomics

We are a Saudi Biotech company focused on localizing and applying technologies in genomics & multi-omics. We leverage advanced analytics and data mining to promote health and wellness across the Kingdom and the region.

  • Leading genomics innovation in the Middle East
  • Empowering precision medicine and preventive healthcare
  • Partnering with academic, clinical, and research institutions
  • Committed to Saudi Vision 2030 in biotech and health sectors
3+
Years of Experience
0+
Patients Tested
Healthcare consultation
Medical facility
Medical staff
Cardiology Services
CEO. Novo Genomics

Message from the CEO

At Novo Genomics, we are honored to stand at the forefront of precision medicine in Saudi Arabia and the broader Middle East. Our journey is guided by a singular vision: to harness the power of genomics, data science, and next-generation biotechnology to transform healthcare delivery, improve patient outcomes, and contribute to a knowledge-based, innovation-driven economy.

As a Saudi-founded biotechnology company, we are deeply committed to developing solutions that are scientifically rigorous, regionally relevant, and clinically impactful. Through investments in localized research, strategic international collaborations, and cutting-edge technologies, we address critical gaps in diagnostics, preventive care, and population health—while upholding the highest standards of quality, ethics, and data integrity. We take pride in supporting healthcare institutions, clinicians, and patients with a growing portfolio of genomic innovations that align with the Kingdom’s national priorities and the aspirations of Vision 2030. We also believe that sustained impact requires strategic collaboration—with government stakeholders, academic institutions, and the global scientific community. At Novo Genomics, we are driven by purpose, powered by science, and inspired by the opportunity to shape the future of healthcare in the region and beyond. Thank you for your continued trust.

Dr. Abdulelah Alhawsawi

CEO, Novo Genomics

Our Core Values

Guiding principles that drive our innovation and commitment to excellence in genomics

Our Vision

To Transform health and wellness by harnessing the power of genomics and multi omics, making precision medicine accessible for all.

Our Mission

We are Saudi biotech company focused on leading and applying technologies in genomics and multi omics and leveraging through advance analytics and data mining to promote personalized health & wellness in the region and beyond.

Our Values

Client Commitment
Information Accessibility
Customer-Oriented
Passion for Science

The leaderships

Leading with Vision, Expertise, and Compassion.

Dr. Abdulelah Alhawsawi, Ph.D.

Dr.Abdulelah Alhawsawi, Ph.D.

CEO

Former Founding Director General of the Saudi Patient Safety Center (SPSC), and Advisor to the Ministry of Health on Patient Safety. Trusted consultant to several national and international healthcare organizations. A board-certified surgeon (American & Canadian).

Dr Abdulrahman Asiri, Ph.D.

Dr.Abdulrahman Asiri, Ph.D.

Bioinformatics and Data Director

Bioinformatician and expert in human population genetics, GWAS, and cardiovascular genetics. Asiri specializes in developing advanced bioinformatics pipelines to analyze large-scale biological datasets, with a focus on identifying genetic drug targets and novel genes through extensive data analysis tools.

Dr Bader Almuzzaini

Dr.Bader Almuzzaini

Genomic Lab Director

Genetic Laboratory Consultant and expert in cytogenetics, molecular genetics, diagnostic genomics, and clinical research tools. Primarily focused on genomic profiling of congenital disorders and fetal cancers.

Dr Budoor Almansour, Ph.D.

Dr.Budoor Almansour, Ph.D.

COO

With over 10 years of experience in healthcare, life sciences, and biotechnology, Budoor has led development projects and implemented innovative strategies for sustainable growth. She has worked across multidisciplinary teams within multinational companies in China, Australia, and the UAE, bringing a global perspective to every initiative.

Dr Amera MD, Ph.D.

Dr.Amerh Alqahtani MD, Ph.D.

Clinical Genomics Lead

10 years of a professional expectance in the medial genetics , Academia, with certified medical genetics board from France working with government and privet hospital

Partners and Collaborations

Together, we drive innovation and shape the future of precision medicine through trusted partnerships.

JCI Accreditation
NABH Certification
ISO 9001
CAP Accreditation
Medical Board
Healthcare Association
Healthcare Association
Healthcare Association
Healthcare Association
Healthcare Association
Healthcare Association
Healthcare Association
Healthcare Association